Viewing Study NCT06132503


Ignite Creation Date: 2025-12-24 @ 7:30 PM
Ignite Modification Date: 2025-12-25 @ 5:11 PM
Study NCT ID: NCT06132503
Status: RECRUITING
Last Update Posted: 2025-03-17
First Post: 2023-11-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors
Sponsor: Lantern Pharma Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module